Anouk W. M. A. Schaeffers

Agreement and Reliability of Cone-Beam Computed Tomography Scans to Assess Skeletal Muscle Mass During Radiotherapy in Patients with Head and Neck Squamous Cell Carcinoma

Anouk W. M. A. Schaeffers, Eline R. du Pon, Ernst J. Smid, Jan Willem Dankbaar et autres

nl (code pays fourni par la source)

The Prognostic Effect of Sarcopenia in Solid Cancers Treated with Immunotherapy: A Systematic Review and Meta-Analysis

Laura F. J. Huiskamp, Anouk W. M. A. Schaeffers, Lot A. Devriese, R. de Bree

de, nl (code pays fourni par la source)

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy

Anouk V. M. Burger, Charlotte W. Duinkerken, Eleonoor A. R. Theunissen, Anouk W. M. A. Schaeffers et autres

nl, de (code pays fourni par la source)

Cisplatin dose limiting toxicity and skeletal muscle mass in head and neck cancer patients: The effect of skeletal muscle mass on dose limiting toxicities and potential solutions

Anouk W. M. A. Schaeffers, MS Hoofd-Hals Chirurgische Oncologie, Cancer, Remco de Bree et autres

Cisplatin dose limiting toxicity and skeletal muscle mass in head and neck cancer patients

Anouk W. M. A. Schaeffers

it (code pays fourni par la source)

The predictive and prognostic role of radiologically defined sarcopenia in head and neck cancer: a systematic review and multi-level meta-analysis

Hugo C. van Heusden, Maartje A. van Beers, Anouk W. M. A. Schaeffers, Justin E. Swartz et autres

nl (code pays fourni par la source)

Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation

Anouk V. M. Burger, Dorieke E M van Balen, Anouk W. M. A. Schaeffers, Charlotte L. Zuur et autres

nl (code pays fourni par la source)

Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma

Anouk W. M. A. Schaeffers, Hannah A. Scholten, Annemieke Kok, Floris C.J. Reinders et autres

nl (code pays fourni par la source)

Effect of hydration schedules on dose‐limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatin

Anouk W. M. A. Schaeffers, Cassimy B. van Neerven, D. van Balen, Mirjam Crul et autres

nl (code pays fourni par la source)

How do patients with head and neck cancer and low skeletal muscle mass experience cisplatin-based chemoradiotherapy? A qualitative study

Anouk W. M. A. Schaeffers, Maartje A. van Beers, Lot A. Devriese, Frank Klomp et autres

nl (code pays fourni par la source)

The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis

Anouk W. M. A. Schaeffers, Hannah A. Scholten, Maartje A. van Beers, B W Meussen et autres

nl (code pays fourni par la source)

The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma

Anouk W. M. A. Schaeffers, Anouk V. M. Burger, Charlotte W. Duinkerken, Klaske E. van Sluis et autres

nl, de (code pays fourni par la source)